Literature DB >> 23052486

The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.

Mehmet Melikoglu1, Meltem Alkan Melikoglu.   

Abstract

Behçet's disease (BD) is a chronic disorder characterized by mucocutaneous and multisystem manifestations. Fibromyalgia (FM) is characterized by widespread musculoskeletal pain and may be present concomitantly with several rheumatic diseases. Our aims were to investigate the prevalence of FM in patients with BD and to evaluate the possible relation of FM presence with BD disease activity. A total of 104 Behcet patients were included in this study. Age, sex, disease durations and the BD Current Activity Form (BDCAF) scores as disease activity evaluation were recorded. Presence of FM and the Fibromyalgia Impact Questionnaire (FIQ) scores was investigated. Also, ESR and CRP concentrations were determined in all patients. Mann-Whitney U test and Pearson's correlation tests were used for the statistical analysis. There were 60 female and 40 male patients with an age range of 19-51 years. Eighteen of 100 BD patients were diagnosed as FM. Although ages, disease duration and laboratory parameters did not differ between BD patients with and without FM, BD patients with FM were more frequently female (p < 0.000). The presence of FM did not differ significantly between patients with and without systemic manifestations. Also, oral-genital ulcers, erythema nodosum, thrombophlebitis, pustular lesions and doctor's impression of disease activity scores were not found to be different in BD patients with or without FM. However, there were significant differences in fatigue, headache, arthralgia and patient impression of disease activity (today and last 28 days) between these groups (p < 0.000; p < 0.01; p < 0.01; p = 0.021 and p = 0.027, respectively). Also, there were significant correlations between BDCAF and FIQ items that refer pain and fatigue (p < 0.01). FM is a common and important clinical problem that may represent an additional factor that worsens pain and physical limitations in patients with BD. The higher prevalence of FM in patients with BD seems to be affected by BD itself, rather than its severity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052486     DOI: 10.1007/s00296-012-2530-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome.

Authors:  V Hamuryudan; I Fresko; H Direskeneli; M J Tenant; S Yurdakul; T Akoglu; H Yazici
Journal:  Rheumatology (Oxford)       Date:  1999-08       Impact factor: 7.580

2.  Fibromyalgia in inflammatory bowel disease.

Authors:  D Buskila; L R Odes; L Neumann; H S Odes
Journal:  J Rheumatol       Date:  1999-05       Impact factor: 4.666

3.  Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability.

Authors:  A Naranjo; S Ojeda; F Francisco; C Erausquin; I Rúa-Figueroa; C Rodríguez-Lozano
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

4.  Fibromyalgia in Iraqi patients with Behcet's disease.

Authors:  Mustafa K Al-Izzi; Abul Sattar Jabber
Journal:  J Med Liban       Date:  2004 Apr-Jun

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Levent Ediz; Ozcan Hiz; Murat Toprak; Ibrahım Tekeoglu; Songul Ercan
Journal:  Clin Rheumatol       Date:  2010-08-12       Impact factor: 2.980

Review 7.  Improving the recognition and diagnosis of fibromyalgia.

Authors:  Lesley M Arnold; Daniel J Clauw; Bill H McCarberg
Journal:  Mayo Clin Proc       Date:  2011-05       Impact factor: 7.616

8.  Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  J Rheumatol       Date:  2004-04       Impact factor: 4.666

9.  The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus.

Authors:  G D Middleton; J E McFarlin; P E Lipsky
Journal:  Arthritis Rheum       Date:  1994-08

10.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

View more
  9 in total

1.  Fibromyalgia in Behçet's disease: a narrative review.

Authors:  Claire Jobanputra; Roberta H Richey; Jagdish Nair; Robert J Moots; Andreas Goebel
Journal:  Br J Pain       Date:  2017-03-22

Review 2.  Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis.

Authors:  Fatemeh Heidari; Mahdi Afshari; Mahmood Moosazadeh
Journal:  Rheumatol Int       Date:  2017-04-26       Impact factor: 2.631

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

5.  Coexistence of Familial Mediterranean Fever With Ankylosing Spondylitis and Sjogren's Syndrome: A Rare Occurrence.

Authors:  Fulya Dörtbaş; Yeşim Garip; Tuba Güler; Ayşe Aslıhan Karci
Journal:  Arch Rheumatol       Date:  2015-11-03       Impact factor: 1.472

6.  The frequency and effect of fibromyalgia in patients with Behçet's disease.

Authors:  Murat Toprak; Metin Erden; Mahmut Alpaycı; Levent Ediz; Levent Yazmalar; Özcan Hız; İbrahim Tekeoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2017-06-03

Review 7.  Triggering agents and microbiome as environmental factors on Behçet's syndrome.

Authors:  Gonca Mumcu; Haner Direskeneli
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

8.  The Frequency of Fibromyalgia and its Relationship With Disease Activity in Female Patients With Behçet's Disease: A Cross Sectional Study.

Authors:  Koray Ayar; Burcu Metİn Ökmen; Lale Altan; Esra KÖsegİl ÖztÜrk
Journal:  Arch Rheumatol       Date:  2020-01-08       Impact factor: 1.472

9.  Fibromyalgia Syndrome and Vitiligo: A Novel Association.

Authors:  Oula S Khudhair; Faiq I Gorial; Ammar F Hameed
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.